⌘K

Login Start Free

Home/Filings/4/0001171843-25-000826

4//SEC Filing

Chiniara Ellen 4

Accession 0001171843-25-000826

CIK 0001738021other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 5:09 PM ET

Size

5.4 KB

Accession

0001171843-25-000826

Insider Transaction Report

Form 4

Period: 2025-02-11

Compass Therapeutics, Inc.CMPX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-02-11+40,000→ 40,000 total
Exercise: $3.65Exp: 2035-02-11→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1

filerCIK 0001398764

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 5:09 PM ET
Size: 5.4 KB

View on SEC.gov